MRNA

Moderna, Inc. · Healthcare · Biotechnology
$67.44
+0.43 (+0.64%)
Mkt Cap: 26.76B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield-18.0%
Dividend YieldN/A
Market Cap26.76B
Volume5.81M
Recent News
Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies
proactiveinvestors.com · 2026-07-14
Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies
proactiveinvestors.com · 2026-07-14
Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note
zacks.com · 2026-07-13
Arbutus Biopharma: Moderna Validates My IP Bull Case
seekingalpha.com · 2026-07-13
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout
247wallst.com · 2026-07-10
Moderna wins EU contract for RSV vaccine supply
reuters.com · 2026-07-09

Unlock the Full Deep Scan

9 AI agents analyze MRNA across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →